Skip to main content
Log in

The temporal trends in association between newer medications and diabetic retinopathy

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ntentakis DP, Correa VSMC, Ntentaki AM, Delavogia E, Narimatsu T, Efstathiou NE, Vavvas DG (2023) Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06236-5

  2. Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, Chilton R (2020) Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond. Cardiovasc Endocrinol Metab 10(1):3–13. https://doi.org/10.1097/XCE.0000000000000209

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nadelmann JB, Miller CG, McGeehan B, Yu Y, VanderBeek BL (2023) SGLT2 inhibitors and diabetic retinopathy progression. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06273-0

  4. Sharma A, Parachuri N, Kumar N, Saboo B, Tripathi HN, Kuppermann BD, Bandello F (2022) Semaglutide and the risk of diabetic retinopathy-current perspective. Eye (Lond) 36(1):10–11. https://doi.org/10.1038/s41433-021-01741-5

    Article  CAS  PubMed  Google Scholar 

  5. Hebsgaard JB, Pyke C, Yildirim E, Knudsen LB, Heegaard S, Kvist PH (2018) Glucagon-like peptide-1 receptor expression in the human eye. Diabetes Obes Metab 20(9):2304–2308. https://doi.org/10.1111/dom.13339.9507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George I. Varughese.

Ethics declarations

Conflict of interest

None — SJ is a consultant ophthalmologist leading a regional retinopathy screening service and treating patients with diabetic retinopathy, and GIV is a consultant physician managing patients with diabetes mellitus–related complications.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jacob, S., Varughese, G.I. The temporal trends in association between newer medications and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 262, 1369–1370 (2024). https://doi.org/10.1007/s00417-023-06357-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-023-06357-x

Navigation